This was the most recent recall.
[URL unfurl="true"]https://www.businesstoday.in/current/corporate/sun-pharma-recalls-36275-cartons-of-testosterone-injection-in-us/story/430549.html[/URL]
Pharma major Sun Pharmaceutical Industries is recalling 36,275 cartons of a drug used to treat low testosterone levels in the US market for incorrect labeling. The Testosterone Cypionate Injection is being recalled in the American market by the US arm of Sun Pharma, as per the latest enforcement report of the US Food and Drug Administration. The company started the nationwide recall on January 11, 2021.
[URL unfurl="true"]https://www.thehindubusinessline.com/companies/sun-pharma-recalls-testosterone-injection-in-the-us-for-labelling-error/article33774329.ece[/URL]
Elaborating on the reasons for the Class III recall, the USFDA said: "Incorrect Labelling: Incorrect lot number on secondary packaging." As per the USFDA, a class III recall is initiated in a "situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences".
The company initiated the nationwide recall on January 11, 2021.
